id: NEW:trimethylamine_n_oxide_tmao_level_to_all_cause_mortality_rate
name: Trimethylamine N-oxide (TMAO) Level â†’ All-Cause Mortality Rate
from_node:
  node_id: NEW:trimethylamine_n_oxide_tmao_level
  node_name: Trimethylamine N-oxide (TMAO) Level
to_node:
  node_id: all_cause_mortality_rate
  node_name: All-Cause Mortality Rate
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Gut microbiota metabolize dietary nutrients (choline, carnitine, betaine
  from red meat, eggs, fish) to produce trimethylamine (TMA)'
- 'Step 2: TMA is absorbed and oxidized to trimethylamine N-oxide (TMAO) by hepatic
  flavin monooxygenases'
- 'Step 3: Elevated circulating TMAO promotes inflammation, as evidenced by positive
  correlation with inflammatory biomarkers (r = 0.43)'
- 'Step 4: TMAO contributes to kidney dysfunction and is inversely correlated with
  glomerular filtration rate (r = -0.49), creating a vicious cycle in CKD patients'
- 'Step 5: TMAO promotes cardiovascular damage through pro-atherogenic effects, endothelial
  dysfunction, and platelet hyperreactivity'
- 'Step 6: Combined kidney-heart damage from chronic TMAO elevation increases risk
  of cardiovascular events and all-cause mortality'
evidence:
  quality_rating: A
  n_studies: 21
  primary_citation: 'Yachun Li et al. 2023. Gut microbiota-derived trimethylamine
    N-oxide is associated with the risk of all-cause and cardiovascular mortality
    in patients with chronic kidney disease: a systematic review and dose-response
    meta-analysis. Annals medicus.'
  supporting_citations: []
description: Elevated circulating trimethylamine N-oxide (TMAO), a gut microbiota-derived
  metabolite, is linearly associated with increased all-cause mortality risk in chronic
  kidney disease patients. This meta-analysis of 21 studies (n=15,637) demonstrates
  that highest TMAO concentrations increase mortality risk by 26% in non-dialysis
  CKD patients and 62% in non-black dialysis patients. The mechanism involves TMAO-induced
  inflammation, impaired kidney function, and cardiovascular damage.
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
quantitative_effects:
  effect_size:
    value: 1.26
    type: relative_risk
    ci_lower: 1.03
    ci_upper: 1.54
  p_value: 0.028
  sample_size: 15637
moderators:
- name: dialysis_status
  direction: strengthens
  strength: moderate
  description: Association present in both non-dialysis CKD patients (RR=1.26) and
    non-black dialysis patients (RR=1.62), with stronger effect in dialysis patients
- name: race
  direction: weakens
  strength: strong
  description: Black dialysis patients showed no significant association between TMAO
    and mortality, potentially due to genetic or dietary factors
- name: kidney_function
  direction: strengthens
  strength: strong
  description: Strong negative correlation between TMAO and GFR (r=-0.49) indicates
    impaired renal clearance amplifies TMAO accumulation and associated mortality
    risk
